A 503A pharmacy compounds semaglutide using bulk pharmaceutical-grade powder or concentrate, then adds sterile diluents and, in some cases, preservatives to extend stability
However, its important to keep in mind that regardless of whether a person has diabetes, they can experience side effects from semaglutide injections
Medi-Cal will continue to cover GLP-1s when used for FDA-approved, non-weight-loss indications (e.g., type 2 diabetes, ASCVD, CKD) with appropriate ICD-10 codes and, when required, prior authorization
Research is ongoing on dozens of other potential indications
Understanding Tirzepatide and Its Uses Tirzepatide is a relatively new medication that has gained attention for its effectiveness in managing type 2 diabetes and aiding weight loss